Actively Recruiting
Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
Led by Omphis Foundation · Updated on 2024-09-19
15000
Participants Needed
1
Research Sites
261 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The current observational study aims to perform the sentinel lymph node in breast cancer in the usual way with technetium 99 and add a second tracer, indocyanine green. The objective is to evaluate the detection rate of the lymph node with indocyanine green compared to the usual technique.
CONDITIONS
Official Title
Selective Sentinella Lymph Node Biopsy with Indocyanine Green in Patients with Breast Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients >18 years of age with breast cancer who are candidates for sentinel lymph node detection
- N0 patients or patients who have undergone target axillary detection with good response
You will not qualify if you...
- Lymphadenectomy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Sandra Lopez Gordo
Cerdanyola del Vallès, Barcelona, Spain, 08290
Actively Recruiting
Research Team
S
Sandra Lopez gordo
CONTACT
S
Sandra Lopez gordo
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here